Dr. Harrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Office of the Dean
1300 York Avenue, F-113
New York, NY 10065Phone+1 212-746-6005
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
- UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 2012 - 2025
- NY State Medical License 2023 - 2025
- NC State Medical License 1993 - 2017
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor Start of enrollment: 2006 Apr 01
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. Start of enrollment: 2006 Sep 01
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Representation of Women Among Cardiology Grand Rounds Speakers in the United States.Ersilia M DeFilippis, Supriya Muppala, Gurleen Kaur, Jessica H Huston, Robert A Harrington
JAMA Cardiology. 2024-12-23 - 3 citationsApolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.C Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White
European Heart Journal. 2024-12-16 - ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.C Michael Gibson, Gerald Chi, Danielle Duffy, M Cecilia Bahit, Harvey White
Journal of the American College of Cardiology. 2024-11-26
Journal Articles
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
- Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER TrialPaolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect
Press Mentions
- This Week in CardiologyNovember 22nd, 2024
- Brooks School, Weill Cornell Medicine Launch Center to Improve Health PolicyNovember 19th, 2024
- American Heart Association to Honor 8 Cardiology LeadersNovember 6th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: